ANTIPLATELET DRUGS

被引：8

作者：

FITZGERALD, GA

MEAGHER, EA

机构：

[1] Centre for Cardiovascular Science, Department of Medicine and Experimental Therapeutics, University College, Dublin

来源：

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 1994年 / 24卷

基金：

英国惠康基金;

关键词：

ANTIPLATELET COMPOUNDS; ASPIRIN; DIPYRIDAMOLE; TICLOPIDINE; GPIIB/IIIA;

D O I：

10.1111/j.1365-2362.1994.tb02427.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The evidence in support of the safety and efficacy of aspirin in the secondary prevention of platelet dependent vascular-occlusion is compelling. The utility of this drug has stalled the development of potential competitors, such as thromboxane antagonists. The emergence of glycoprotein IIb/IIIa antagonists as the most promising competitors for aspirin has focused attention on the possibility of delivering these drugs at an effective dose safely.

引用

页码：46 / 49

页数：4

共 41 条

[21] HUMAN PLATELET ERYTHROLEUKEMIA CELL PROSTAGLANDIN G/H SYNTHASE - CDNA CLONING, EXPRESSION, AND GENE CHROMOSOMAL ASSIGNMENT [J].

FUNK, CD ;

FUNK, LB ;

KENNEDY, ME ;

PONG, AS ;

FITZGERALD, GA .

FASEB JOURNAL, 1991, 5 (09) :2304-2312

[22] PHARMACODYNAMIC STUDY OF F(AB')2 FRAGMENTS OF MURINE MONOCLONAL ANTIBODY-7E3 DIRECTED AGAINST HUMAN PLATELET GLYCOPROTEIN-IIB/IIIA IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS [J].

GOLD, HK ;

GIMPLE, LW ;

YASUDA, T ;

LEINBACH, RC ;

WERNER, W ;

HOLT, R ;

JORDAN, R ;

BERGER, H ;

COLLEN, D ;

COLLER, BS .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :651-659

[23] LOW-DOSE ASPIRIN AND SUBSEQUENT PERIPHERAL ARTERIAL-SURGERY IN THE PHYSICIANS HEALTH STUDY [J].

GOLDHABER, SZ ;

MANSON, JE ;

STAMPFER, MJ ;

LAMOTTE, F ;

ROSNER, B ;

BURING, JE ;

HENNEKENS, CH .

LANCET, 1992, 340 (8812) :143-145

[24] A RANDOMIZED TRIAL COMPARING TICLOPIDINE HYDROCHLORIDE WITH ASPIRIN FOR THE PREVENTION OF STROKE IN HIGH-RISK PATIENTS [J].

HASS, WK ;

EASTON, JD ;

ADAMS, HP ;

PRYSEPHILLIPS, W ;

MOLONY, BA ;

ANDERSON, S ;

KAMM, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (08) :501-507

[25] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY [J].

HENNEKENS, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :129-135

[26] HUMAN CYCLOOXYGENASE-2 CDNA [J].

HLA, T ;

NEILSON, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7384-7388

[27]

JONES DA, 1993, J BIOL CHEM, V268, P9049

[28] TRANSDERMAL MODIFICATION OF PLATELET-FUNCTION - A DERMAL ASPIRIN PREPARATION SELECTIVELY INHIBITS PLATELET CYCLOOXYGENASE AND PRESERVES PROSTACYCLIN BIOSYNTHESIS [J].

KEIMOWITZ, RM ;

PULVERMACHER, G ;

MAYO, G ;

FITZGERALD, DJ .

CIRCULATION, 1993, 88 (02) :556-561

[29]

KUJUBU DA, 1992, J BIOL CHEM, V267, P7991

[30]

MEADE EA, 1993, J BIOL CHEM, V268, P6610

← 1 2 3 4 5 →